Evidence map›Paper›PMID 32477963›Full record

ReviewFrontiers in cellular and infection microbiology2020

Host Immunity to

Florian Sparber, Fiorella Ruchti, Salomé LeibundGut-Landmann

Abstract readReview
In one paragraph

Review in Frontiers in cellular and infection microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Article
  2. Article
  3. Microbiota in cancer: current understandings and future perspectives.Signal transduction and targeted therapy · 2026
    Review
  4. Review
  5. Effects ofInternational journal of microbiology · 2025
    Article
  6. Article
  7. Regulatory Ability ofJournal of fungi (Basel, Switzerland) · 2023
    Article
  8. Impact of Exposomes on Ocular Surface Diseases.International journal of molecular sciences · 2023
    Review
  9. Article
  10. Interactions betweenInternational journal of molecular sciences · 2023
    Article
  11. Article
  12. Polygalaxanthone III, an Active Ingredient inMolecules (Basel, Switzerland) · 2022
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. [Malassezia spp.: interactions with topically applied lipids-a review : Malassezia and topically applied lipids].Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete · 2021
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Florian SparberSection of Immunology, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland.
Fiorella RuchtiSection of Immunology, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland.
Salomé LeibundGut-LandmannSection of Immunology, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The microbiota plays an integral role in shaping physical and functional aspects of the skin. While a healthy microbiota contributes to the maintenance of immune homeostasis, dysbiosis can result in the development of diverse skin pathologies. This dichotomous feature of the skin microbiota holds true not only for bacteria, but also for fungi that colonize the skin. As such, the yeast

Indexed as

MalasseziaMicrobiotaAnimalsFungiQuality of LifeSkincommensalismcutaneous immunityimmunopathologyMalasseziamycobiota

Identifiers

PMID32477963
PMCPMC7232612

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.